EDAP TMS reported EUR12.92M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
AngioDynamics USD 36.57M 3.79M Sep/2025
Boston Scientific USD 1.68B 120M Sep/2026
EDAP TMS EUR 12.92M 4.1M Mar/2026
Henry Schein USD 831M 22M Jun/2026
Medtronic 3.2B 141M Jun/2026
Plus Therapeutics USD 4.26M 779K Mar/2026
Veracyte USD 55.71M 4.87M Jun/2026